Review



ribotm fluorescent in situ hybridisation kit  (Ribobio co)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Ribobio co ribotm fluorescent in situ hybridisation kit
    Ribotm Fluorescent In Situ Hybridisation Kit, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+in+situ+hybridisation+kit/ribotm+fluorescent+in+situ+hybridization+kit/pm40436288-112-16-7
    Average 90 stars, based on 1 article reviews
    ribotm fluorescent in situ hybridisation kit - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Fluorescence:

    Article Title: Mechanical force-sensitive lncRNA SNHG8 inhibits osteogenic differentiation by regulating EZH2 in hPDLSCs.
    Article Snippet: .. The fluorescence in situ hybridisation (FISH) assay was performed using a Fluorescence in Situ Hybridisation Kit (Ribobio, Guangzhou, China) according to the manufacturer's instructions. .. After being fixed in 4% paraformaldehyde (Solarbio), PDLSCs were washed with phosphatebuffered saline (PBS) containing 0.5% Triton X-100 (Solarbio) to increase cell permeability.

    Article Title: circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4.
    Article Snippet: The circASAP1 oligonucleotide probe with Cy3 fluorescent labeling was synthesized by RiboBio, China. .. The probe was hybridised into cells using a fluorescence in situ hybridisation kit (RiboBio, China). .. Images were taken by a confocal laser scanning microscope (FV1000, Olympus, Japan).

    In Situ:

    Article Title: Mechanical force-sensitive lncRNA SNHG8 inhibits osteogenic differentiation by regulating EZH2 in hPDLSCs.
    Article Snippet: .. The fluorescence in situ hybridisation (FISH) assay was performed using a Fluorescence in Situ Hybridisation Kit (Ribobio, Guangzhou, China) according to the manufacturer's instructions. .. After being fixed in 4% paraformaldehyde (Solarbio), PDLSCs were washed with phosphatebuffered saline (PBS) containing 0.5% Triton X-100 (Solarbio) to increase cell permeability.

    Article Title: circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4.
    Article Snippet: The circASAP1 oligonucleotide probe with Cy3 fluorescent labeling was synthesized by RiboBio, China. .. The probe was hybridised into cells using a fluorescence in situ hybridisation kit (RiboBio, China). .. Images were taken by a confocal laser scanning microscope (FV1000, Olympus, Japan).

    Hybridization:

    Article Title: Mechanical force-sensitive lncRNA SNHG8 inhibits osteogenic differentiation by regulating EZH2 in hPDLSCs.
    Article Snippet: .. The fluorescence in situ hybridisation (FISH) assay was performed using a Fluorescence in Situ Hybridisation Kit (Ribobio, Guangzhou, China) according to the manufacturer's instructions. .. After being fixed in 4% paraformaldehyde (Solarbio), PDLSCs were washed with phosphatebuffered saline (PBS) containing 0.5% Triton X-100 (Solarbio) to increase cell permeability.

    Article Title: circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4.
    Article Snippet: The circASAP1 oligonucleotide probe with Cy3 fluorescent labeling was synthesized by RiboBio, China. .. The probe was hybridised into cells using a fluorescence in situ hybridisation kit (RiboBio, China). .. Images were taken by a confocal laser scanning microscope (FV1000, Olympus, Japan).

    Fluorescence In Situ Hybridization:

    Article Title: Mechanical force-sensitive lncRNA SNHG8 inhibits osteogenic differentiation by regulating EZH2 in hPDLSCs.
    Article Snippet: .. The fluorescence in situ hybridisation (FISH) assay was performed using a Fluorescence in Situ Hybridisation Kit (Ribobio, Guangzhou, China) according to the manufacturer's instructions. .. After being fixed in 4% paraformaldehyde (Solarbio), PDLSCs were washed with phosphatebuffered saline (PBS) containing 0.5% Triton X-100 (Solarbio) to increase cell permeability.

    other:

    Article Title: circRNA_0005529 facilitates growth and metastasis of gastric cancer via regulating miR-527/Sp1 axis.
    Article Snippet: A fluorescence in situ hybridisation (FISH) kit (RiboBio) was used to perform FISH.



    Similar Products

    90
    Advanced Cell Diagnostics Inc fluorescence in situ hybridisation fish rnascope multiplex fluorescent reagent kit version 2
    Fluorescence In Situ Hybridisation Fish Rnascope Multiplex Fluorescent Reagent Kit Version 2, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+in+situ+hybridisation+kit/fluorescence+in+situ+hybridisation+fish+rnascope+multiplex+fluorescent+reagent+kit+version+2/pm39603502-150-9-21
    Average 90 stars, based on 1 article reviews
    fluorescence in situ hybridisation fish rnascope multiplex fluorescent reagent kit version 2 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    GenScript corporation fluorescence in situ hybridisation (fish) kit
    Fluorescence In Situ Hybridisation (Fish) Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+in+situ+hybridisation+kit/fluorescence+in+situ+hybridisation++fish++kit/pm40435734-93-11-17
    Average 90 stars, based on 1 article reviews
    fluorescence in situ hybridisation (fish) kit - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Ribobio co ribotm fluorescent in situ hybridisation kit
    Ribotm Fluorescent In Situ Hybridisation Kit, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+in+situ+hybridisation+kit/ribotm+fluorescent+in+situ+hybridization+kit/pm40436288-112-16-7
    Average 90 stars, based on 1 article reviews
    ribotm fluorescent in situ hybridisation kit - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Ribobio co fluorescent in situ hybridisation kit r11060
    Fluorescent In Situ Hybridisation Kit R11060, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+in+situ+hybridisation+kit/ribotm+fluorescent+in+situ+hybridization+kit/pmc11967755-258-16-20
    Average 90 stars, based on 1 article reviews
    fluorescent in situ hybridisation kit r11060 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Shanghai GenePharma fluorescence in situ hybridisation kit
    Fluorescence In Situ Hybridisation Kit, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+in+situ+hybridisation+kit/fluorescent+in+situ+hybridization+kit/pm39923929-130-5-10
    Average 90 stars, based on 1 article reviews
    fluorescence in situ hybridisation kit - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Ribobio co fluorescence in situ hybridisation kit
    Fluorescence In Situ Hybridisation Kit, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+in+situ+hybridisation+kit/ribotm+fluorescent+in+situ+hybridization+kit/pm39748364-80-8-13
    Average 90 stars, based on 1 article reviews
    fluorescence in situ hybridisation kit - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Ribobio co fluorescence situ hybridisation kit
    Fluorescence Situ Hybridisation Kit, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+in+situ+hybridisation+kit/ribotm+fluorescent+in+situ+hybridization+kit/pmc11694429-72-8-13
    Average 90 stars, based on 1 article reviews
    fluorescence situ hybridisation kit - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    99
    Advanced Cell Diagnostics Inc fluorescence in situ hybridisation
    Selective and efficient chemogenetic activation of cNTS PPG neurons in vivo. A) Schematic of injection protocol. B) Representative images of RNAscope in situ <t>hybridisation</t> for Ppg mRNA (yellow) and immunolabelling for mCherry (to detect hM3Dq:mCherry, red) in tissue from one Glu-Cre/tdRFP mice injected with AAV8-DIO-hM3Dq:mCherry. Scale bars: 100 μm. C) Percent of Ppg- expressing neurons in the cNTS also expressing hM3Dq:mCherry (efficiency), as well as percent of mCherry-expressing cNTS neurons also expressing Ppg (selectivity). Results from control mice (expressing mCherry only, n = 2) are indicated with black circles, while results from hM3Dq-expressing mice (n = 2) are indicated with green triangles. D) Representative images of immunohistochemical labelling for cFOS (black nuclear label) and dsRed (brown cytoplasmic label, detecting mCherry and tdRFP) in mice expressing mCherry only (control, top panels) or hM3Dq:mCherry (hM3Dq, bottom panels) injected with saline (2 ml/kg, left panels) or CNO (2 mg/kg, 2 ml/kg; right panels). Scale bar: 100 μm. E) Percent of mCherry-expressing cNTS neurons also labelled for cFOS in control (grey/black) and hM3Dq-expressing (green) mice injected with saline (2 ml/kg, pattern) or CNO (2 mg/kg, filled). Data from females are indicated by circles; males are indicated by triangles. Also shown is Gardner-Altman estimation plot showing the mean difference in activated neurons between saline and CNO-injected hM3Dq-expressing mice. Two-way drug × virus interaction: F(1,32) = 138.9, p < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Fluorescence In Situ Hybridisation, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+in+situ+hybridisation+kit/RNAscope+Multiplex+Fluorescent+Reagent+Kit+v2/pmc11667184-129-5-17
    Average 99 stars, based on 1 article reviews
    fluorescence in situ hybridisation - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Advanced Cell Diagnostics Inc rnascope fluorescent in situ hybridisation
    List of human FFPE PM tissue used for <t> in situ hybridisation </t>
    Rnascope Fluorescent In Situ Hybridisation, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+in+situ+hybridisation+kit/RNAscope+Multiplex+Fluorescent+Detection+Kit+v2/pmc11492505-104-0-6
    Average 99 stars, based on 1 article reviews
    rnascope fluorescent in situ hybridisation - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    90
    Ribobio co ribo fluorescent in situ hybridisation kit
    Binding of IFIH1‐binding RNA 1 (IBR1) to IFIH1. (A) RNA fluorescence in situ <t>hybridisation</t> (FISH) and immunofluorescence (IF) experiments revealed that IBR1 co‐localised with IFIH1 in bone marrow‐derived macrophages (BMDMs). Scale bar: 25 µm. (B) RNA immunoprecipitation (RIP)‒PCR detection of the enrichment of IFIH1 on IBR1 in BMDMs. Immunoglobulin G (IgG) was used as the negative control. (C) Electrophoretic mobility shift assays (EMSAs) revealed that IBR1 binds to IFIH1 in vitro. (D and E) Silver staining of gels after sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS‒PAGE) and Western blotting revealed that IFIH1 was enriched, as determined by IBR1 pull‐down assays.
    Ribo Fluorescent In Situ Hybridisation Kit, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+in+situ+hybridisation+kit/ribotm+fluorescent+in+situ+hybridization+kit/pmc11420289-145-15-22
    Average 90 stars, based on 1 article reviews
    ribo fluorescent in situ hybridisation kit - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Selective and efficient chemogenetic activation of cNTS PPG neurons in vivo. A) Schematic of injection protocol. B) Representative images of RNAscope in situ hybridisation for Ppg mRNA (yellow) and immunolabelling for mCherry (to detect hM3Dq:mCherry, red) in tissue from one Glu-Cre/tdRFP mice injected with AAV8-DIO-hM3Dq:mCherry. Scale bars: 100 μm. C) Percent of Ppg- expressing neurons in the cNTS also expressing hM3Dq:mCherry (efficiency), as well as percent of mCherry-expressing cNTS neurons also expressing Ppg (selectivity). Results from control mice (expressing mCherry only, n = 2) are indicated with black circles, while results from hM3Dq-expressing mice (n = 2) are indicated with green triangles. D) Representative images of immunohistochemical labelling for cFOS (black nuclear label) and dsRed (brown cytoplasmic label, detecting mCherry and tdRFP) in mice expressing mCherry only (control, top panels) or hM3Dq:mCherry (hM3Dq, bottom panels) injected with saline (2 ml/kg, left panels) or CNO (2 mg/kg, 2 ml/kg; right panels). Scale bar: 100 μm. E) Percent of mCherry-expressing cNTS neurons also labelled for cFOS in control (grey/black) and hM3Dq-expressing (green) mice injected with saline (2 ml/kg, pattern) or CNO (2 mg/kg, filled). Data from females are indicated by circles; males are indicated by triangles. Also shown is Gardner-Altman estimation plot showing the mean difference in activated neurons between saline and CNO-injected hM3Dq-expressing mice. Two-way drug × virus interaction: F(1,32) = 138.9, p < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Molecular Metabolism

    Article Title: Modulation of stress-related behaviour by preproglucagon neurons and hypothalamic projections to the nucleus of the solitary tract

    doi: 10.1016/j.molmet.2024.102076

    Figure Lengend Snippet: Selective and efficient chemogenetic activation of cNTS PPG neurons in vivo. A) Schematic of injection protocol. B) Representative images of RNAscope in situ hybridisation for Ppg mRNA (yellow) and immunolabelling for mCherry (to detect hM3Dq:mCherry, red) in tissue from one Glu-Cre/tdRFP mice injected with AAV8-DIO-hM3Dq:mCherry. Scale bars: 100 μm. C) Percent of Ppg- expressing neurons in the cNTS also expressing hM3Dq:mCherry (efficiency), as well as percent of mCherry-expressing cNTS neurons also expressing Ppg (selectivity). Results from control mice (expressing mCherry only, n = 2) are indicated with black circles, while results from hM3Dq-expressing mice (n = 2) are indicated with green triangles. D) Representative images of immunohistochemical labelling for cFOS (black nuclear label) and dsRed (brown cytoplasmic label, detecting mCherry and tdRFP) in mice expressing mCherry only (control, top panels) or hM3Dq:mCherry (hM3Dq, bottom panels) injected with saline (2 ml/kg, left panels) or CNO (2 mg/kg, 2 ml/kg; right panels). Scale bar: 100 μm. E) Percent of mCherry-expressing cNTS neurons also labelled for cFOS in control (grey/black) and hM3Dq-expressing (green) mice injected with saline (2 ml/kg, pattern) or CNO (2 mg/kg, filled). Data from females are indicated by circles; males are indicated by triangles. Also shown is Gardner-Altman estimation plot showing the mean difference in activated neurons between saline and CNO-injected hM3Dq-expressing mice. Two-way drug × virus interaction: F(1,32) = 138.9, p < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: Tissue sections were processed using fluorescence in situ hybridisation (FISH, RNAscope Multiplex Fluorescent Reagent Kit version 2, Advanced Cell Diagnostics [ACD], #323100) to label preproglucagon ( Ppg ), Crhr1 and Crhr2 mRNA transcripts in the cNTS and Crh mRNA transcripts in the PVN.

    Techniques: Activation Assay, In Vivo, Injection, RNAscope, In Situ, Hybridization, Expressing, Control, Immunohistochemical staining, Saline, Virus

    Ch emogenetic inhibition of NTS-projecting PVN neurons. A) Diagram of the experimental paradigm for chemogenetic inhibition of NTS-projecting PVN neurons. B) cFOS immunoreactivity (magenta nuclei, pseudocolour) and EGFP or mCherry immunofluorescence (greyscale) labelling in the PVN of a representative control mouse (left, EGFP) and a representative hM4Di-expressing mouse (right, hM4Di) after i.p. injection of CNO (2 mg/kg, 2 ml/kg) followed by 30 min restraint stress. 3V: third ventricle. Scale bar: 100 μm. C) Calculated percentage of EGFP- vs. hM4Di:mCherry-expressing (fluorescent protein, FP+) cells that were also cFOS-positive in mice after i.p. injection of CNO (2 mg/kg, 2 ml/kg) followed by exposure to an acute stressor (novel environment or restraint stress). Unpaired T-test: t = 2.498, df = 6. D) Representative images of cFOS-immunoreactivity in the cNTS of mice expressing EGFP (top) or hM4Di (bottom) in NTS-projecting PVN neurons. Counted cFOS-immunoreactive cells indicated with rainbow-coloured mask to the right. All mice were injected with CNO (2 mg/kg, 2 ml/kg) and then exposed to novel environment or restraint stress. Scale bar: 100 μm. E) Counts of cFOS-immunoreactive nuclei in the cNTS in mice expressing EGFP or hM4Di in NTS-projecting PVN neurons and injected with CNO (2 mg/kg, 2 ml/kg) prior to stress exposure. Unpaired T-test: t = 3.603, df = 11. F) cFOS- and GLP-1-immunoreactivity in the cNTS of mice expressing EGFP (top) or hM4Di (bottom) in NTS-projecting PVN neurons and injected with CNO (2 mg/kg, 2 ml/kg) prior to stress exposure. Scale bar: 100 μm. G) Calculated percentage of GLP-1-immunoreactive cells in the cNTS that were also cFOS-IR. Unpaired T-test: t = 2.766, df = 6. H) Cumulative chow intake over 4 h after dark onset in mice expressing EGFP or hM4Di in NTS-projecting PVN neurons after injection with saline (2 ml/kg; dashed lines) or CNO (2 mg/kg, 2 ml/kg; solid lines). I) Chow intake over the first 2 h of dark phase in mice expressing EGFP or hM4Di in NTS-projecting PVN neurons after injection with saline (2 ml/kg) or CNO (2 mg/kg, 2 ml/kg). J) Chow intake during the first 2 h of dark onset of mice expressing EGFP or hM4Di in NTS-projecting PVN neurons and injected with CNO (2 mg/kg, 2 ml/kg) prior to 30 min restraint stress. Virus × stress interaction: F(1, 6) = 7.805, p = 0.0314. K) The relationship between activation of NTS-projecting PVN neurons and stress-induced hypophagia. The effect of stress on 2 h food intake in mice expressing EGFP (grey squares) or hM4Di (magenta circles) in NTS-projecting PVN neurons is plotted against the percentage of cFOS-positive NTS-projecting PVN neurons. L) Representative images of RNAscope in situ hybridisation for Crh (magenta in merged image) combined with immunolabelling for GFP (green in merged image) and oxytocin (cyan in merged image) in the PVN of mice expressing GFP in NTS-projecting PVN neurons. Scale bar: 100 μm. Yellow arrowheads indicate Crh- positive EGFP-labelled neurons; red arrows indicate oxytocin-positive EGFP-labelled neurons; yellow arrows indicate EGFP-labelled neurons positive for both Crh and oxytocin. M) Percentage of NTS-projecting PVN neurons expressing Crh and/or oxytocin (OT+). N = 3 mice, 2 sections containing the PVN from each mouse. N) Diagram illustrating RNAscope in situ labelling for Crh in cells with direct projections to NTS PPG neurons (RABV-GFP labelled). O) RNAscope in situ hybridisation for Crh in PPG-projecting PVN neurons (RABV-GFP labelled). Scale bar top panel: 100 μm. White arrowheads indicate Crh -positive RABV-GFP labelled neurons. Bottom panel: higher magnification image of inset in top panel. Scale bar: 20 μm. Gardner-Altman estimation plots in panels C, E, G, I, and J display estimated effect sizes for each assessed parameter. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Molecular Metabolism

    Article Title: Modulation of stress-related behaviour by preproglucagon neurons and hypothalamic projections to the nucleus of the solitary tract

    doi: 10.1016/j.molmet.2024.102076

    Figure Lengend Snippet: Ch emogenetic inhibition of NTS-projecting PVN neurons. A) Diagram of the experimental paradigm for chemogenetic inhibition of NTS-projecting PVN neurons. B) cFOS immunoreactivity (magenta nuclei, pseudocolour) and EGFP or mCherry immunofluorescence (greyscale) labelling in the PVN of a representative control mouse (left, EGFP) and a representative hM4Di-expressing mouse (right, hM4Di) after i.p. injection of CNO (2 mg/kg, 2 ml/kg) followed by 30 min restraint stress. 3V: third ventricle. Scale bar: 100 μm. C) Calculated percentage of EGFP- vs. hM4Di:mCherry-expressing (fluorescent protein, FP+) cells that were also cFOS-positive in mice after i.p. injection of CNO (2 mg/kg, 2 ml/kg) followed by exposure to an acute stressor (novel environment or restraint stress). Unpaired T-test: t = 2.498, df = 6. D) Representative images of cFOS-immunoreactivity in the cNTS of mice expressing EGFP (top) or hM4Di (bottom) in NTS-projecting PVN neurons. Counted cFOS-immunoreactive cells indicated with rainbow-coloured mask to the right. All mice were injected with CNO (2 mg/kg, 2 ml/kg) and then exposed to novel environment or restraint stress. Scale bar: 100 μm. E) Counts of cFOS-immunoreactive nuclei in the cNTS in mice expressing EGFP or hM4Di in NTS-projecting PVN neurons and injected with CNO (2 mg/kg, 2 ml/kg) prior to stress exposure. Unpaired T-test: t = 3.603, df = 11. F) cFOS- and GLP-1-immunoreactivity in the cNTS of mice expressing EGFP (top) or hM4Di (bottom) in NTS-projecting PVN neurons and injected with CNO (2 mg/kg, 2 ml/kg) prior to stress exposure. Scale bar: 100 μm. G) Calculated percentage of GLP-1-immunoreactive cells in the cNTS that were also cFOS-IR. Unpaired T-test: t = 2.766, df = 6. H) Cumulative chow intake over 4 h after dark onset in mice expressing EGFP or hM4Di in NTS-projecting PVN neurons after injection with saline (2 ml/kg; dashed lines) or CNO (2 mg/kg, 2 ml/kg; solid lines). I) Chow intake over the first 2 h of dark phase in mice expressing EGFP or hM4Di in NTS-projecting PVN neurons after injection with saline (2 ml/kg) or CNO (2 mg/kg, 2 ml/kg). J) Chow intake during the first 2 h of dark onset of mice expressing EGFP or hM4Di in NTS-projecting PVN neurons and injected with CNO (2 mg/kg, 2 ml/kg) prior to 30 min restraint stress. Virus × stress interaction: F(1, 6) = 7.805, p = 0.0314. K) The relationship between activation of NTS-projecting PVN neurons and stress-induced hypophagia. The effect of stress on 2 h food intake in mice expressing EGFP (grey squares) or hM4Di (magenta circles) in NTS-projecting PVN neurons is plotted against the percentage of cFOS-positive NTS-projecting PVN neurons. L) Representative images of RNAscope in situ hybridisation for Crh (magenta in merged image) combined with immunolabelling for GFP (green in merged image) and oxytocin (cyan in merged image) in the PVN of mice expressing GFP in NTS-projecting PVN neurons. Scale bar: 100 μm. Yellow arrowheads indicate Crh- positive EGFP-labelled neurons; red arrows indicate oxytocin-positive EGFP-labelled neurons; yellow arrows indicate EGFP-labelled neurons positive for both Crh and oxytocin. M) Percentage of NTS-projecting PVN neurons expressing Crh and/or oxytocin (OT+). N = 3 mice, 2 sections containing the PVN from each mouse. N) Diagram illustrating RNAscope in situ labelling for Crh in cells with direct projections to NTS PPG neurons (RABV-GFP labelled). O) RNAscope in situ hybridisation for Crh in PPG-projecting PVN neurons (RABV-GFP labelled). Scale bar top panel: 100 μm. White arrowheads indicate Crh -positive RABV-GFP labelled neurons. Bottom panel: higher magnification image of inset in top panel. Scale bar: 20 μm. Gardner-Altman estimation plots in panels C, E, G, I, and J display estimated effect sizes for each assessed parameter. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: Tissue sections were processed using fluorescence in situ hybridisation (FISH, RNAscope Multiplex Fluorescent Reagent Kit version 2, Advanced Cell Diagnostics [ACD], #323100) to label preproglucagon ( Ppg ), Crhr1 and Crhr2 mRNA transcripts in the cNTS and Crh mRNA transcripts in the PVN.

    Techniques: Inhibition, Immunofluorescence, Control, Expressing, Injection, Saline, Virus, Activation Assay, RNAscope, In Situ, Hybridization

    List of human FFPE PM tissue used for  in situ hybridisation

    Journal: Acta Neuropathologica Communications

    Article Title: Mapping the glial transcriptome in Huntington’s disease using snRNAseq: selective disruption of glial signatures across brain regions

    doi: 10.1186/s40478-024-01871-3

    Figure Lengend Snippet: List of human FFPE PM tissue used for in situ hybridisation

    Article Snippet: RNAScope fluorescent in situ hybridisation (FISH; ACD Bio) was carried out using the RNAScope Multiplex Fluorescent v2 kit (323110) according to manufacturer’s instructions, using the standard pretreatment conditions.

    Techniques: In Situ, Hybridization

    PDE1A upregulation in oligodendrocytes in HD (A) We identified upregulation of PDE1A across multiple clusters and regions. (B) Violin plots of expression of PDE1A in different regions and different clusters comparing HD and control donors. Stars represent adjusted p-values from MAST, *** p < 0.001. (C) Duplex RNAScope identification of PDE1A transcript (yellow) in MBP-expressing (red) oligodendroglia in human HD brain. DAPI-stained nuclei in blue. (D) BaseScope identification of PDE1A transcript (blue) in OLIG2 transcript-expressing (pink) oligodendroglia in human HD brain. (E) Dot plot showing expression of immune markers across microglial subclusters

    Journal: Acta Neuropathologica Communications

    Article Title: Mapping the glial transcriptome in Huntington’s disease using snRNAseq: selective disruption of glial signatures across brain regions

    doi: 10.1186/s40478-024-01871-3

    Figure Lengend Snippet: PDE1A upregulation in oligodendrocytes in HD (A) We identified upregulation of PDE1A across multiple clusters and regions. (B) Violin plots of expression of PDE1A in different regions and different clusters comparing HD and control donors. Stars represent adjusted p-values from MAST, *** p < 0.001. (C) Duplex RNAScope identification of PDE1A transcript (yellow) in MBP-expressing (red) oligodendroglia in human HD brain. DAPI-stained nuclei in blue. (D) BaseScope identification of PDE1A transcript (blue) in OLIG2 transcript-expressing (pink) oligodendroglia in human HD brain. (E) Dot plot showing expression of immune markers across microglial subclusters

    Article Snippet: RNAScope fluorescent in situ hybridisation (FISH; ACD Bio) was carried out using the RNAScope Multiplex Fluorescent v2 kit (323110) according to manufacturer’s instructions, using the standard pretreatment conditions.

    Techniques: Expressing, Control, RNAscope, Staining

    The molecular co-chaperone BAG3 is upregulated in HD microglia in a separate cohort. A-B . Double in situ hybridisation ( A ) on a separate human brain tissue cohort showing an increase ( B ) in microglia ( ITGAM +, red) expressing BAG3 , green. Arrow for double-positive cell. Plot shows median and range. (Welch Two Sample t-test, p-value = 0.023). C-D . Double in situ hybridisation ( C ) showing OPCs ( PDGFRa +, red) expressing BAG3 , green ( D ). Plot shows median and range (Wilcoxon rank sum test, p-value = 0.1). DAPI-stained nuclei coloured blue in images

    Journal: Acta Neuropathologica Communications

    Article Title: Mapping the glial transcriptome in Huntington’s disease using snRNAseq: selective disruption of glial signatures across brain regions

    doi: 10.1186/s40478-024-01871-3

    Figure Lengend Snippet: The molecular co-chaperone BAG3 is upregulated in HD microglia in a separate cohort. A-B . Double in situ hybridisation ( A ) on a separate human brain tissue cohort showing an increase ( B ) in microglia ( ITGAM +, red) expressing BAG3 , green. Arrow for double-positive cell. Plot shows median and range. (Welch Two Sample t-test, p-value = 0.023). C-D . Double in situ hybridisation ( C ) showing OPCs ( PDGFRa +, red) expressing BAG3 , green ( D ). Plot shows median and range (Wilcoxon rank sum test, p-value = 0.1). DAPI-stained nuclei coloured blue in images

    Article Snippet: RNAScope fluorescent in situ hybridisation (FISH; ACD Bio) was carried out using the RNAScope Multiplex Fluorescent v2 kit (323110) according to manufacturer’s instructions, using the standard pretreatment conditions.

    Techniques: In Situ, Hybridization, Expressing, Staining

    Binding of IFIH1‐binding RNA 1 (IBR1) to IFIH1. (A) RNA fluorescence in situ hybridisation (FISH) and immunofluorescence (IF) experiments revealed that IBR1 co‐localised with IFIH1 in bone marrow‐derived macrophages (BMDMs). Scale bar: 25 µm. (B) RNA immunoprecipitation (RIP)‒PCR detection of the enrichment of IFIH1 on IBR1 in BMDMs. Immunoglobulin G (IgG) was used as the negative control. (C) Electrophoretic mobility shift assays (EMSAs) revealed that IBR1 binds to IFIH1 in vitro. (D and E) Silver staining of gels after sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS‒PAGE) and Western blotting revealed that IFIH1 was enriched, as determined by IBR1 pull‐down assays.

    Journal: Clinical and Translational Medicine

    Article Title: IBR1, a novel endogenous IFIH1‐binding dsRNA, governs IFIH1 activation and M1 macrophage polarisation in ARDS

    doi: 10.1002/ctm2.70027

    Figure Lengend Snippet: Binding of IFIH1‐binding RNA 1 (IBR1) to IFIH1. (A) RNA fluorescence in situ hybridisation (FISH) and immunofluorescence (IF) experiments revealed that IBR1 co‐localised with IFIH1 in bone marrow‐derived macrophages (BMDMs). Scale bar: 25 µm. (B) RNA immunoprecipitation (RIP)‒PCR detection of the enrichment of IFIH1 on IBR1 in BMDMs. Immunoglobulin G (IgG) was used as the negative control. (C) Electrophoretic mobility shift assays (EMSAs) revealed that IBR1 binds to IFIH1 in vitro. (D and E) Silver staining of gels after sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS‒PAGE) and Western blotting revealed that IFIH1 was enriched, as determined by IBR1 pull‐down assays.

    Article Snippet: Fluorescence in situ hybridisation (FISH) was conducted on BMDMs or CD14 + monocytes utilising the Ribo Fluorescent In Situ Hybridisation Kit from Ribo Bio.

    Techniques: Binding Assay, Fluorescence, In Situ, Hybridization, Immunofluorescence, Derivative Assay, RNA Immunoprecipitation, Negative Control, Electrophoretic Mobility Shift Assay, In Vitro, Silver Staining, Polyacrylamide Gel Electrophoresis, Western Blot